Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
---|
11/04/1999 | CA2330563A1 Therapeutic anti-cold agent containing isomalt as an active ingredient |
11/04/1999 | CA2328165A1 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies |
11/03/1999 | EP0952873A1 Targeted hysteresis hyperthermia as a method for treating diseased tissue |
11/03/1999 | EP0952854A2 Composition comprising non-radioactive metal ion complexes with phosphonate compounds for the palliation of pain associated with diseases of the bone and bone joints |
11/03/1999 | EP0952851A1 Anti-carious chewing gums, candies, gels, toothpastes and dentifrices |
11/03/1999 | CN1234072A Anti-ErbB2 antibodies |
11/03/1999 | CN1233964A Anti-carious chewing gums, candies, gels, toothpaste and dentifrices |
11/03/1999 | CN1233494A Infantile plaster for relieving cough |
11/03/1999 | CN1233482A Application of selenium-rich glossy ganoderma in medicine for treating psoriasis |
11/03/1999 | CN1233476A Medicine for treating acute leukemia, and method for preparing same |
11/03/1999 | CN1233472A Toxin decontaminant food product and method of forming same |
11/03/1999 | CN1233471A Medicinal prepns. for treating underarm odour and beriberi |
11/03/1999 | CN1233470A Electrolysis of water resulting in reduction of fat content in human liver |
11/03/1999 | CN1046091C Oolong medicinal products, pellet or tablet thereof |
11/02/1999 | US5976579 Mixture of carbonate, chelate compound, vitamin and minerals |
11/02/1999 | US5976509 Aqueous solution containing from 0.1% wt/vol to 10% wt/vol potassium chloride, and an amount of calcium hypochlorite suitable to yield about 5% wt/vol of active chlorine dissolved in water. |
11/02/1999 | CA2126729C Hydrogen peroxide composition |
10/28/1999 | WO1999053969A1 Preparation for regenerating collagen |
10/28/1999 | WO1999053898A1 Implants for administering substances and methods of producing implants |
10/28/1999 | WO1999042839A3 Treating cancer |
10/28/1999 | CA2320135A1 Preparation for regenerating collagen |
10/27/1999 | EP0951842A2 Infant formula |
10/27/1999 | EP0951470A1 Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients |
10/27/1999 | EP0951292A1 Methods for treating an ischemic disorder and improving stroke outcome |
10/27/1999 | EP0951288A1 Reactive oxygen intermediates containing compounds effective in inducing cell differentiation of malignant cells such as leukemia |
10/27/1999 | EP0951286A2 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations |
10/27/1999 | CN1233171A Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin |
10/27/1999 | CN1232702A Mastopathy treating ointment |
10/27/1999 | CN1232701A Process for preparing herbal compositions for treatment of bronchitis and respiratory disorders with anticancer properties |
10/27/1999 | CN1232681A Hog cholera treating medicine |
10/26/1999 | US5972999 Pharmaceutical compositions and methods for improving wrinkles and other skin conditions |
10/26/1999 | US5972987 Detection lice with dye |
10/26/1999 | US5972967 Intravenous administering 2-(butylsulfonylamino)-3-(4-(4-(piperidin-4-yl)butoxyphenyl)pr opionic acid |
10/26/1999 | US5972920 Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders |
10/26/1999 | US5972390 Method of treating depression and pre-menstrual syndrome using chromium |
10/26/1999 | US5972367 A sugar, amino acids, electrolytes and a fat emulsion for nutrient supply use. |
10/26/1999 | US5972345 Comprising saw palmetto extract, african pygeum extract, stinging nettle extract |
10/26/1999 | CA2132993C Physiologically active substance |
10/23/1999 | CA2268541A1 Zinc remedy for treating common cold |
10/21/1999 | WO1999052542A1 Use of erythropoietin for the treatment of haemochromatoses |
10/21/1999 | WO1999040941A8 A fish scale extract as a calcium supplement |
10/21/1999 | WO1999039707A8 Metal-thiols as immunomodulating agents |
10/21/1999 | WO1995026768A9 Methods for treating pulmonary vasoconstriction and asthma |
10/21/1999 | DE19848597A1 Stabilized compositions useful for stimulating collagen neogenesis in treatment of bone defects |
10/20/1999 | CN1231922A Medicine for treatment of cancer |
10/20/1999 | CN1231921A Traditional Chinese medicine plaster for treating osteoproliferation |
10/20/1999 | CN1231918A Human immunization strengthening medicine |
10/20/1999 | CN1231916A Hepatitis restoration pill |
10/20/1999 | CN1231901A Mongolia patent drug for treating peptic ulcer, and its producing method |
10/20/1999 | CN1231897A Liquid medicine for treatment of bromidrosis, and its preparing method |
10/20/1999 | CN1231896A Specific treatment of common cold, virus flu, and others against cause of diseases |
10/19/1999 | US5968976 Gastrointestinal tract disorders |
10/19/1999 | US5968966 Non-oral administering of composition containing l-carnosine |
10/19/1999 | US5968726 Blood substitute of aqueous solution of hydroxyethyl starch, simple sugar, dynamic buffer, sodium ions, chloride ions, magnesium ions, potassium ions, and calcium ions; with subphysiological concentrations of potassium; autoclavable |
10/19/1999 | US5968253 Calcium phosphate cements comprising antimicrobial agents |
10/14/1999 | WO1999051585A1 Composition for the treatment of cancer and colitis ulcerosa as well as the use of a titanium complex and a zinc salt for the preparation of the composition |
10/14/1999 | WO1999051277A1 Enhancement of cellular gallium uptake |
10/14/1999 | WO1999051246A1 Antitumor agents |
10/14/1999 | DE19913089A1 Composition comprising plant extracts from at least two of Bryonia, Ipecacuanha or Drosera, and antimony potassium tartrate, useful for treatment of chronic obstructive pulmonary disease, bronchitis, respiratory disorders and cancer |
10/14/1999 | CA2325353A1 Enhancement of cellular gallium uptake |
10/13/1999 | EP0949203A1 Fine cisplatin powder and process for the production thereof |
10/13/1999 | EP0948357A1 Use of low molecular weight amino alcohols in ophthalmic compositions |
10/13/1999 | EP0948334A1 Method of treating prostatic diseases using active vitamin d analogues |
10/13/1999 | EP0948265A1 A method to prepare food seasoning, food ingredient and food item compositions, seasoning and use thereof |
10/13/1999 | CN1231582A Use of bilayer forming emulsifiers in nutritional compositions comprising divalent metal salts |
10/13/1999 | CN1231185A Medicine for curing psychosis and preparation process thereof |
10/13/1999 | CN1231180A Detoxifying medicine and preparation process thereof |
10/13/1999 | CN1231175A Fluoracyl melatonin and composition and preparation thereof |
10/13/1999 | CN1231174A Medicinal compositions for curing cardio-vascular diseases and benign prostatomegaly |
10/13/1999 | CN1045537C Traditional Chinese medicinal pillfor curing gonorrhea and preparation process thereof |
10/13/1999 | CN1045536C Plaster for curing fracture |
10/13/1999 | CN1045535C Xifengdingjian pill preparation process capable of calming endopathic wind alleviating epilepsy |
10/12/1999 | US5965625 Consists of a xanthine oxidase inhibitor, a phosphate or a compound capable of releasing phosphate on administering to a patient; enzyme inhibitor are selected from a flavanoid, purines, quinazoline, traiazine and pyrazalo(3,4-d)pyrimidine |
10/12/1999 | US5965610 Mixture containing chlorhexidine gluconate and zinc gluconate |
10/12/1999 | US5965581 Composition of 2-s-(n-butylsulfonylamino)-3-(4-(4-(piperidin-4-yl)butyloxy)phenyl)propionic acid, sodium chloride, sodium citrate dihydrate, and citric acid anhydrous, of specific osmolality; prevents thrombosis |
10/12/1999 | US5965137 Insect repellent composition and method for inhibiting the transmission and treatment of symptoms of vector-borne diseases |
10/12/1999 | US5965118 Polymer-platinum compounds |
10/07/1999 | WO1999049868A1 Sustained-release composition containing cefaclor |
10/07/1999 | WO1999049716A2 Method for producing liposomal formulations of active agents by high-pressure homogenisation |
10/06/1999 | EP0946501A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
10/06/1999 | EP0946197A1 Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients |
10/06/1999 | CN1230891A Lectin compositions and uses thereof |
10/06/1999 | CN1230429A Medicine for trachitis and its preparation |
10/06/1999 | CN1230421A Chinese medicine preparation for curing residual jaundice of viral hepatitis |
10/06/1999 | CN1230415A Combined Chinese and Western medicine for treating nevus and its preparation |
10/06/1999 | CN1045392C Internal guide therapeutic medicine for rheumatoid disease and making method |
10/06/1999 | CN1045391C Oral delivery system |
10/06/1999 | CN1045389C Healthy medicine and its medicine bag for external use |
10/06/1999 | CN1045383C Medicine composition for curing senile cataract |
10/06/1999 | CN1045382C Chloramphenicol eye drop contg. sodium hyaluronic acid and its preparation |
10/05/1999 | US5962733 Aqueous solution containing glucose |
10/05/1999 | US5962549 Composite prosthetic containing polyolefin binder and bioactive glass |
10/05/1999 | US5962517 Pharmaceutical compositions and methods for treating acne |
10/05/1999 | US5962420 Wound healing agents; drug delivery; crosslinking fibrin |
10/05/1999 | US5962048 Veterinary pharmaceutical method of administration |
10/05/1999 | US5962032 Aqueous solutions based on magnesium, potassium, sodium and optionally calcium salts, at least one sugar and at least one amino acid, combined with a copper salt or a zinc salt. |
10/05/1999 | US5962026 Solid compositions of fibrin monomer |
10/05/1999 | US5962020 Composition and method for preventing and/or treating microalbuminuria |
10/05/1999 | US5961993 Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the treatment of acne |
10/05/1999 | US5961988 Barium or strontium hexaferrite single crystals, samarium-cobalt particles and neodymium-iron-boron particles; aggregates consist of fluorocarbons and natural phospholipids with a phosphatidylcholine content of 30 to 99 wt %. |